Small molecule drugs represent nearly 90% of pharmaceutical products available in the market. In fact, in 2019, the FDA’s Center for Drug Evaluation and Research approved 48 drugs, of which, 67% were small molecules. However, drug development and manufacturing is a cost intensive process, and is, at times, characterized by the need for advanced capabilities and specialized facilities, which are not possible for all developer companies to build in-house
Cwin Nha Cai Hang Dau Chau A
Fiance Visa Uk
Business Manager
Marathon Moving Services
So Do 66
Dentsaregone
Vreeland Remodeling
Cetakkain
Tahana Akther
Delightdentalspa